Reuters logo
BRIEF-Ebola drug ZMapp granted orphan designation by European Medicines Agency
October 15, 2015 / 3:10 PM / in 2 years

BRIEF-Ebola drug ZMapp granted orphan designation by European Medicines Agency

Oct 15 (Reuters) -

* Mapp Biopharmaceutical says Ebola drug ZMapp granted orphan medicinal product designation by European Medicines Agency

* Mapp says EMA designation “another crucial step toward approval of ZMapp” (Reporting by UK bureau)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below